IVUS Catheters Market Report (2023 to 2031) – Abbott, GE HealthCare, Medtronic plc, ICU Medical Inc., and Boston Scientific Corporation

Newark, New Castle, USA, June 20, 2023 (GLOBE NEWSWIRE) — According to the most recent study by Growth Plus Reports, the global IVUS catheters market was valued at US$ 627.1 million and is expected to rise at a revenue CAGR of 6.9% to reach US$ 1,143.1 million by 2031.

The global market for IVUS catheters was analyzed, and it is expected to rise significantly during the forecast period. Intravascular ultrasound (IVUS) catheters analyze blood vessel tissue by introducing a tiny tube into the blood vessel to discover and treat cardiovascular disorders by collecting clear pictures internally from blood vessels. 

Recent Development in the Global IVUS Catheters Market: 

• In February 2023, the US FDA granted Northeast Scientific Inc. 510(k) certification for the reprocessed Philips IVUS Eagle Eye Platinum RX Digital catheter. 
• In July 2022, intravascular Imaging Inc. launched the 3 Fr NIRF-IVUS imaging equipment for human coronary imaging.

Request a Free Sample PDF: https://www.growthplusreports.com/inquiry/request-sample/ivus-catheters-market/8640                                 

                                                   IVUS Catheters Market Scope

Key Takeaways: 

• Growing demand for the non-invasive and precise diagnostic method drives the market revenue share.
• The early detection of heart conditions for effective treatment is driving the demand for IVUS catheters.
• Several advancements and increasing R&D activities are creating a strong product pipeline.

Market Drivers and Restraints: 

The driving factor for the IVUS catheters market revenue is its accuracy, safety, and growing need for non-invasive procedures. Furthermore, IVUS catheters offer enhanced accuracy, minimal invasiveness, and real-time monitoring, contributing to market revenue growth. 

However, reusing disposable IVUS catheters and rising prices to endanger patient safety are expected to restrain market revenue growth. 

Request for Customization – https://www.growthplusreports.com/inquiry/customization/ivus-catheters-market/8640

Market Segmentation: 

Segmentation By Modality

Based on modality, the global IVUS catheters market is segmented into virtual histology IVUS, iMap IVUS, and integrated backscatter IVUS. Due to the change in caliber and a better understanding of intravascular ultrasound imaging, the virtual histology IVUS segment accounts for the largest market revenue share. 

Segmentation By Type

Based on type, the global IVUS catheter market is segmented into mechanical IVUS catheters, solid-state IVUS catheters, digital IVUS catheters, and others. The mechanical IVUS catheters segment accounts for the largest market revenue share due to the small transducers, enabling critical procedures and real-time imaging during catheterization procedures.

Segmentation By Indication

Based on indication, the global IVUS catheters market is segmented into aortic aneurysms, blood clots, coronary artery diseases, and deep vein thrombosis. The coronary artery disease segment accounts for the largest market revenue share due to its rising prevalence, consequences for death and disability, and enormous financial burden.

Segmentation By End-User

Based on the end-user, the global IVUS catheters market is segmented into hospitals, ambulatory surgical centers, diagnostic imaging centers, and others. The hospital segment accounts for the largest revenue share as angiography, electrophysiological testing, and other catheter-based procedures used to identify cardiovascular disorders are often performed in hospitals.

Regional Growth Dynamics

Based on the region, the global IVUS catheters market is segmented into North America, Asia Pacific, Latin America, Europe, and the Middle East & Africa. Due to chronic disease prevalence, high healthcare costs, and modern healthcare infrastructure, North America accounts for the largest revenue share in the global market.

Competitive Landscape

Following is a list of the top market players operating in the global market for IVUS catheters: 

• Cordis
• GE HealthCare
• Abbott
• ACIST Medical Systems
• Boston Scientific Corporation
• Cook Medical

Report Coverage 

Growth Plus Reports studied the global market for IVUS catheters in-depth and analyzed the basic market characteristics, significant investment areas, analytics of regional growth, revenue forecast, competitive market players, mergers, and acquisitions. 

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022) 
   3. Regulatory Landscape
   4. Reimbursement Scenario 
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL IVUS CATHETERS MARKET – ANALYSIS & FORECAST, BY MODALITY
   1. Virtual Histology IVUS
   2. iMap IVUS
   3. Integrated Backscatter IVUS
6. GLOBAL IVUS CATHETERS MARKET – ANALYSIS & FORECAST, BY TYPE
   1. Mechanical IVUS Catheters
   2. Solid-state IVUS Catheters
   3. Digital IVUS Catheters
   4. Others
7. GLOBAL IVUS CATHETERS MARKET – ANALYSIS & FORECAST, BY INDICATION
   1. Aortic Aneurysm
   2. Blood Clots
   3. Coronary Artery Disease
   4. Deep Vein Thrombosis

IVUS CATHETERS MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8640

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market.

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Sympathomimetic Drugs Market by Type (Direct, Indirect, Mized), Indications (Cardiovascular Diseases, Asthma & COPD), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Cortisone Acetate Market by Indication (Rheumatic Diseases, Dermatologic Conditions), Route of Administration (Oral and Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Belladonna Alkaloids Market by Type (Atropine, Hyoscyamine), Application (Gastrointestinal Disorders, Respiratory Disorders, Overactive Bladder), Route of Administration (Oral, Topical), End User (Hospitals, Pharmaceutical Companies)-Global Outlook & Forecast 2023-2031

Calcium Homeostasis Drugs Market by Drug Class (Calcium Metabolism Modifiers, Parathyroid Hormone Analogs), Indication (Hypocalcemia, Hypercalcemia), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Mirvetuximab Soravtansine Market by Indication (Ovarian Cancer, Fallopian Tube Carcinoma), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.